Exosomes from circPTGR1-enriched highly metastatic HCC cells may affect low-metastatic-potential HCC cells by downregulating miR449a-MET interactions in recipient cells, thereby disrupting the homeostasis of the tumor microenvironment and promoting HCC progression. The gene discussed is MET; the disease is hepatocellular carcinoma.